Saturday 17 October 2026
Export HUM’s income statement to Excel — free account
Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
413.16
19.04
−4.41%
Follow HUM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 6.81% | 6.20% | 6.95% | 7.13% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 6 | 8 | |
| 2.38% | 2.13% | 2.49% | 2.59% | ||
ROIC |
17.52% | 14.31% | 16.56% | 20.47% | |
Return on Tangible Assets |
6.67% | 6.03% | 6.38% | 6.85% | |
Average Days of Receivables |
14.27 | 13.88 | 9.20 | 7.75 | |
Free Cash Flow per Share |
16.42 | 10.76 | 3.30 | 12.92 | |
Free Cash Flow |
1,972.00 | 1,295.00 | 398.00 | 1,554.00 | |
Capital Expenditures |
(567.00) | (549.00) | (523.00) | (491.00) | |
| Other line items | |||||
Cash ROIC |
3.44% | 2.37% | 0.80% | 2.91% | |
Accounts Receivable Turnover |
28.57 | 28.36 | 43.41 | 52.35 | |
Accounts Payable Turnover |
19.58 | 19.81 | 20.19 | 18.80 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
21.07 | 20.20 | 18.83 | 18.74 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.18) | (0.16) | (0.16) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.17% | 0.18% | 0.19% | 0.20% | |
Interest Coverage |
3.84 | 3.68 | 4.29 | 4.57 | |
Operating CF/Net income |
1.99 | 1.63 | 0.78 | 1.58 | |
Depreciation/Fixed assets |
0.37 | 0.37 | 0.37 | 0.38 | |
Capex/Depreciation |
(0.73) | (0.68) | (0.63) | (0.56) | |
Revenue per Share |
1,213.32 | 1,140.18 | 1,076.46 | 1,050.63 | |
Operating CF per Share |
21.15 | 15.32 | 7.65 | 17.00 | |
Capex per Share |
(4.72) | (4.56) | (4.34) | (4.08) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates